Literature DB >> 22080244

Cadherin-catenin complex dissociation in lobular neoplasia of the breast.

Mary Morrogh1, Victor P Andrade, Dilip Giri, Rita A Sakr, Wooyul Paik, Li Xuan Qin, Crispinita D Arroyo, Edi Brogi, Monica Morrow, Tari A King.   

Abstract

E-cadherin (E-CD) inactivation with loss of E-CD-mediated cell adhesion is the hallmark of lesions of the lobular phenotype. E-CD is typically absent by immunohistochemistry in both lobular carcinoma in situ (LCIS) and invasive lobular lesions, suggesting it occurs early in the neoplastic process. In laboratory models, downstream post-transcriptional modifiers such as TWIST and SNAIL contribute to the dissociation of the intracellular component of the cadherin-catenin complex (CCC), resulting in tumor progression and invasion. We hypothesized that complete CCC dissociation may play a role in lobular neoplasia progression. Here we explore the relationship between loss of E-CD and dissociation of the CCC in pure LCIS and LCIS associated with invasive cancer. Fresh-frozen tissues were obtained from 36 patients undergoing mastectomy for pure LCIS (n = 11), LCIS with ILC (n = 18) or LCIS with IDC (n = 7). Individual lesions were subject to laser-capture microdissection and gene-expression analysis (Affymetrix HG-U133A 2.0). Immunohistochemistry for ER,PR,HER2, E-CD,N-CD,α-,β-, and phosphoβ-catenin, TWIST, and SNAIL were evaluated in normal, in situ, and invasive components from matched formalin-fixed paraffin-embedded samples (n = 36). CCC-dissociation was defined as negative membranous E-CD, α- and β-catenin expression. E-CD was negative in all LCIS and ILC lesions, and positive in all normal and IDC lesions. Membranous α and β-catenin expressions decreased with the transition from LCIS to ILC (pure LCIS 82%; LCIS w/ILC 28%; ILC 0%), while TWIST expression increased (pure LCIS low; LCIS w/ILC moderate; ILC high). Gene expression paralleled IHC-staining patterns with a stepwise downregulation of E-CD, α and β-catenins from normal to LCIS to invasive lesions, and increasing expression of TWIST from normal to LCIS to ILC. Loss of E-CD expression is an early event in lobular neoplasia. Decreasing membranous catenin expression in tandem with increasing levels of TWIST across the spectrum of lobular lesions suggests that CCC dissociation is a progressive process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080244      PMCID: PMC4349355          DOI: 10.1007/s10549-011-1860-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  41 in total

1.  Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer.

Authors:  Farhad Vesuna; Paul van Diest; Ji Hshiung Chen; Venu Raman
Journal:  Biochem Biophys Res Commun       Date:  2007-12-04       Impact factor: 3.575

Review 2.  The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

Authors:  F Nollet; G Berx; F van Roy
Journal:  Mol Cell Biol Res Commun       Date:  1999-08

3.  Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Authors:  G Acs; T J Lawton; T R Rebbeck; V A LiVolsi; P J Zhang
Journal:  Am J Clin Pathol       Date:  2001-01       Impact factor: 2.493

4.  Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.

Authors:  Luca Morandi; Gianluca Marucci; Maria P Foschini; Maria G Cattani; Annalisa Pession; Cristina Riva; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

5.  Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.

Authors:  Donghui Zou; Han-Seung Yoon; David Perez; Robert J Weeks; Parry Guilford; Bostjan Humar
Journal:  J Pathol       Date:  2009-06       Impact factor: 7.996

6.  Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.

Authors:  E Shelley Hwang; Sarah J Nyante; Yunn Yi Chen; Dan Moore; Sandy DeVries; James E Korkola; Laura J Esserman; Frederic M Waldman
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

7.  E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

Authors:  Xiaolan Qian; Tatiana Karpova; Allan M Sheppard; James McNally; Douglas R Lowy
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

8.  E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.

Authors:  Md Isa Nurismah; O Noriah; M Y Suryati; N A Sharifah
Journal:  Asian Pac J Cancer Prev       Date:  2008 Oct-Dec

Review 9.  E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?

Authors:  Anne-Marie Cleton-Jansen
Journal:  Breast Cancer Res       Date:  2001-11-01       Impact factor: 6.466

10.  Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Authors:  Tarek M A Abdel-Fatah; Desmond G Powe; Zsolt Hodi; Jorge S Reis-Filho; Andrew H S Lee; Ian O Ellis
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

View more
  21 in total

Review 1.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

2.  Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.

Authors:  Marina De Brot; Starr Koslow Mautner; Shirin Muhsen; Victor P Andrade; Anita Mamtani; Melissa Murray; Dilip Giri; Rita A Sakr; Edi Brogi; Tari A King
Journal:  Breast Cancer Res Treat       Date:  2017-06-13       Impact factor: 4.872

3.  SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.

Authors:  Emily A Bossart; Nilgun Tasdemir; Matthew J Sikora; Amir Bahreini; Kevin M Levine; Jian Chen; Ahmed Basudan; Britta M Jacobsen; Timothy F Burns; Steffi Oesterreich
Journal:  Breast Cancer Res Treat       Date:  2019-02-23       Impact factor: 4.872

4.  Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.

Authors:  Victor P Andrade; Mary Morrogh; Li-Xuan Qin; Narciso Olvera; Dilip Giri; Shirin Muhsen; Rita A Sakr; Michail Schizas; Charlotte K Y Ng; Crispinita D Arroyo; Edi Brogi; Agnes Viale; Monica Morrow; Jorge S Reis-Filho; Tari A King
Journal:  Mol Oncol       Date:  2014-12-24       Impact factor: 6.603

Review 5.  Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.

Authors:  Jason A Mouabbi; Amy Hassan; Bora Lim; Gabriel N Hortobagyi; Debasish Tripathy; Rachel M Layman
Journal:  Breast Cancer Res Treat       Date:  2022-03-26       Impact factor: 4.872

6.  Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation.

Authors:  Elaine Zhong; Edi Brogi; Timothy M D'Alfonso; Hannah Wen; Denise Frosina; Nai-Kong Cheung; Achim A Jungbluth; Dara S Ross
Journal:  Appl Immunohistochem Mol Morphol       Date:  2022-02-01

7.  Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.

Authors:  Xiu-Lan Peng; Meng-Yao Ji; Zi-Rong Yang; Jia Song; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

8.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

Authors:  Giovanni Ciriello; Michael L Gatza; Andrew H Beck; Matthew D Wilkerson; Suhn K Rhie; Alessandro Pastore; Hailei Zhang; Michael McLellan; Christina Yau; Cyriac Kandoth; Reanne Bowlby; Hui Shen; Sikander Hayat; Robert Fieldhouse; Susan C Lester; Gary M K Tse; Rachel E Factor; Laura C Collins; Kimberly H Allison; Yunn-Yi Chen; Kristin Jensen; Nicole B Johnson; Steffi Oesterreich; Gordon B Mills; Andrew D Cherniack; Gordon Robertson; Christopher Benz; Chris Sander; Peter W Laird; Katherine A Hoadley; Tari A King; Charles M Perou
Journal:  Cell       Date:  2015-10-08       Impact factor: 41.582

9.  Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.

Authors:  R Mitchell Baldwin; Alan Morettin; Genevieve Paris; Isabelle Goulet; Jocelyn Côté
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

10.  Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast.

Authors:  Joseph L Sottnik; Evelyn K Bordeaux; Sanjana Mehrotra; Sarah E Ferrara; Andrew E Goodspeed; James C Costello; Matthew J Sikora
Journal:  Mol Cancer Res       Date:  2021-05-04       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.